yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47144710-0FB3342C-F167-409F-B9C4-34BD8D06009B
Q47144710-0FB3342C-F167-409F-B9C4-34BD8D06009B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47144710-0FB3342C-F167-409F-B9C4-34BD8D06009B
Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.
P2860
Q47144710-0FB3342C-F167-409F-B9C4-34BD8D06009B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47144710-0FB3342C-F167-409F-B9C4-34BD8D06009B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
921e81534bb775b9bec72ced2f653fa279669a6f
P2860
Gemcitabine at fixed dose-rate in patients with advanced soft-tissue sarcomas: a mono-institutional phase II study.